Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 4/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | DUSP22 | Q9NRW4 | 1/20 | 0.36 |
| ▸ | TPMT | P51580 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24939853 | 0.86 | TSHR (0.45) | MYCESR1ALOX15PTPN7HSD17B10 | |
| SCHEMBL24938796 | 0.85 | MYC (0.54) | MYCESR1ALOX15PTPN7HSD17B10 | |
| SCHEMBL24939682 | 0.84 | MYC (0.55) | MYCESR1ALOX15PTPN7HSD17B10 | |
| SCHEMBL24939670 | 0.82 | MYC (0.45) | MYCESR1ALOX15PTPN7HSD17B10 | |
| SCHEMBL24939798 | 0.81 | TPMT (0.43) | GAANPSR1CA12CA1CA9 | |
| SCHEMBL24939683 | 0.81 | CA12 (0.50) | MYCESR1ALOX15PTPN7HSD17B10 | |
| SCHEMBL24939671 | 0.79 | DDAH1 (0.53) | MYCESR1ALOX15PTPN7HSD17B10 | |
| SCHEMBL8442000 | 0.75 | DDAH1 (0.58) | NPSR1CA12CA1CA9HPGD | |
| SCHEMBL9246650 | 0.74 | TYMS (0.57) | MYCALOX15PTPN7HSD17B10GAA | |
| SCHEMBL24939669 | 0.72 | POLB (0.45) | HSD17B10GAACA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | GFER, LBR, PCNA | MYC 2842/4885ESR1 1520/4885ALOX15 945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.